$PFE Recent News The inscrutable gold timers 10:26 a.m.

New Post Public Reply Private Reply Replies (0) Message Board

Jan 30, 2014 at 1:32 PM

$PFE Recent News

The inscrutable gold timers 10:26 a.m. Today - Mark Hulbert
Updates, advisories and surprises 5:31 p.m. Jan. 28, 2014 - MarketWatch
U.S. stocks rise; Dow breaks 5-day skid 5:02 p.m. Jan. 28, 2014 - Anora Mahmudova
Stocks rebound, helping Dow quit loss streak; Yahoo drops after hours (Stock market live blog recap) 4:31 p.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Stocks back in the win column 4:27 p.m. Jan. 28, 2014 - MarketWatch
Apple sees worst day in a year; Casablanca lifts Cliffs 3:10 p.m. Jan. 28, 2014 - Ben Eisen
Pfizer beats views, even as fourth-quarter sales and earnings slide 12:28 p.m. Jan. 28, 2014 - blogs.marketwatch.com
U.S. stocks rebound on Ford, DuPont; Apple falls 9:37 a.m. Jan. 28, 2014 - Laura Mandaro
Ford shares rise 1%; Pfizer gains 2.6% 9:33 a.m. Jan. 28, 2014 - Laura Mandaro
U.S. stock futures pare gains; Apple weighs on tech 9:19 a.m. Jan. 28, 2014 - Barbara Kollmeyer
Apple's beating, TPDH and America's 'false dawn' recovery 9:17 a.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Fed policymakers gather in Washington 7:30 a.m. Jan. 28, 2014 - MarketWatch
Pfizer profit hurt by generics competition 7:23 a.m. Jan. 28, 2014 - MarketWatch.com
Pfizer shares rise after earnings beat 7:18 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer shares rise 2% premarket 7:10 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer sees 2014 adj. sales of $49.2B to $51.2B 7:09 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer sees 2014 adj. EPS of $2.20 to $2.30 7:08 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 EPS $0.39; Adj. EPS $0.56 7:07 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 profit falls 59% to $2.57 billion 7:07 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 sales down 2% to $13.56 billion 7:06 a.m. Jan. 28, 2014 - Saumya Vaishampayan

Dassault Systemes Acquires Accelrys 11:17 a.m. Today - TheStreet.com
March 7th Options Now Available For Pfizer (PFE) 10:42 a.m. Today - TheStreet.com
9 New Stock Buybacks to Keep on Your Radar 5:14 a.m. Today - InvestorPlace.com
ACCL Stock – Accelrys Shares Skyrocket on Dassault Deal 3:15 a.m. Today - InvestorPlace.com
Pharma Strength Expected To Continue With Eli Lilly 8:53 p.m. Jan. 29, 2014 - Seeking Alpha
Another Strong Earnings Beat from Amgen - Analyst Blog 11:30 a.m. Jan. 29, 2014 - Zacks.com
Stock Market News for January 29, 2014 - Market News 10:06 a.m. Jan. 29, 2014 - Zacks.com
Top Analyst Upgrades and Downgrades: American Airlines, EA, Teradata, VMware, Walmart and More 8:09 a.m. Jan. 29, 2014 - 247WallSt.com
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 29, 2014 - Zacks.com
'Mad Money' Lightning Round: Sell, Sell, Sell Windstream 6:00 a.m. Jan. 29, 2014 - TheStreet.com
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) 5:16 a.m. Jan. 29, 2014 - Seeking Alpha
Don't Underestimate Amgen: Part 2A, Cardiovascular And Oncology Pipeline Products 3:01 a.m. Jan. 29, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Where Have All the Sellers Gone? 8:34 p.m. Jan. 28, 2014 - TheStreet.com
Bitter Medicine in Store for Activists 8:13 p.m. Jan. 28, 2014 - WSJ.com
Bayer's Aleve May Have Lower Cardiac Risk Than Rival Painkillers 7:20 p.m. Jan. 28, 2014 - WSJ.com
Pfizer's CEO Discusses Q4 2013 Results - Earnings Call Transcript 5:04 p.m. Jan. 28, 2014 - Seeking Alpha
The 4 Stocks That Dominated the Market on Tuesday 4:02 p.m. Jan. 28, 2014 - 247WallSt.com
Pfizer coy about split/spinoff plans 2:44 p.m. Jan. 28, 2014 - Seeking Alpha
Pfizer Upbeat About Breast-Cancer Drug, Pneumonia Vaccine 2:29 p.m. Jan. 28, 2014 - WSJ.com
Pfizer Stock Floats on Financial Engineering, Not Growth 5:39 a.m. Jan. 28, 2014 - InvestorPlace.com

Pfizer Reports Fourth-Quarter and Full-Year 2013 Results;Provides 2014 Financial Guidance 7:01 a.m. Jan. 28, 2014 - BusinessWire - BZX
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Maritime Launch Takes Flight with TSX Listing

Turning Point for Maritime Launch Services It's a new dawn for Maritime Launch Services, folks. They're gearing up to list on the Toronto Stock Exchange (TSX) come November 3, under the ticker "MAXQ." It’s like they're strapping rockets to their business model, and it ain’t just for show. A Strategic Move with High Hopes Listing on the TSX isn’t a mere vanity...

Empowering Global Health: Hainan's 2026 Women's Focus

Hainan Hosts a Health Heavyweight Meet Boao, Hainan, not typically on the financial radar, just played host to a global heavyweight—the 2026 International Exchange on Women and Children's Health. While the Wall Street gang's eyes are trained on market tickers, this gathering carried significant strategic weight worth monitoring. This conference attracted over 170 key...

HIZENERGY Sustains Tier 1 Status Amid Tighter Criteria

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...

Ericsson's Drone Tech and Share Buybacks: Impact & Insight

Ericsson's Latest Move into Drone Detection Brace yourself, folks! Ericsson is taking things to a whole new altitude, literally. They're bringing drone detection capabilities right to our mobile networks. It's like they're transforming our standard network towers into stealthy drone spotters. Think about a mobile network that not only keeps your calls from dropping but...

Check Point Q3 2026 Results: Subtle Shifts or a Turning Point?

Digging Deeper into Check Point's Latest Figures When Check Point Software Technologies Ltd. (NASDAQ:CHKP) throws numbers at the wall, not everything sticks, but there's always something telling. The Q3 financial results for 2026 are out, and it's a mixed bag—coffee’s getting cold before you parse through it. Revenue and Subscription Dynamics Let's cut to it: total...

NuvoAutoLinQ Transforms Device Connectivity Management

Leapfrogging the Connectivity Conundrum Picture this: you're staring at a payment terminal that's just as lifeless as your teenager's enthusiasm on a Monday morning. The signal's full bars, yet the device's not connecting. Classic story in the world of connected devices, right? Actually, no more. Enter NuvoLinQ with its snazzy new showcase: NuvoAutoLinQ. This tech...

Wujiang Celebrates 90 Years of Fei Xiaotong's Legacy

If you thought anniversaries were just about looking back, think again! In Wujiang, November 1st was all about forging ahead. Scholars and local officials weren't just reminiscing about Fei Xiaotong's landmark field study at Jiangcun 90 years ago; they were strategizing how to apply the sociologist's insights to today's economic and community challenges. Marking a Legacy...

HashKey and RD Tech Partner for RDUSD Expansion

A Partnership with Serious Implications Here's a fresh duo in the financial frontier—HashKey On-Chain and RD Technologies are teaming up in a bid to push the RDUSD stablecoin into the heart of cross-border trade and finance. And why does it matter? Well, in the wild west of digital finance, stablecoins are the solid ground, and these two are planting their flag. It's a...

Isinwheel's 2027 E-Mobility Pitch: Beyond Resolutions

Embracing the E-Mobility Shift Here we are at the tail end of 2026, and isinwheel is riding high on the wave of New Year resolutions with their hefty e-mobility lineup. It's not just about buying the gear—it's about tackling our reliance on gas-guzzlers with electric scooters and bikes as our trusty steeds. "Reduce car trips? More greenery in your commute? These aren't...

China's Innovation Surge: Game Changer for Global Markets

The Bold Shift in China's Economic Landscape Well, here's the scoop: China isn't just the world's assembly line anymore; it's gearing up to be a top-tier innovation hub. On the surface, might seem like another geopolitical spiel, but dig a little and you'll find it's a serious shake-up for global markets. We're talking about more than just products rolling out of...